Global Strategic Investment Solutions 13F: Exits UNH Stake

Global Strategic Investment Solutions has cut its holdings in UnitedHealth Group Incorporated (NYSE: UNH), selling its entire position of 522 shares in a filing on October 16, 2026. This represents a complete exit from its investment.

What Changed in Global Strategic Investment Solutions' UnitedHealth Position

The fund sold out its position, resulting in a 100% decrease in its stake. After the sale, Global Strategic Investment Solutions owns zero shares of UnitedHealth Group. This cut in position reflects a significant shift in the fund's investment strategy.

Other Institutional Activity in UnitedHealth

Blackrock Inc. reported 76,863,061 shares of UnitedHealth, adding 3,394,259 shares for a 4.6% increase. Vanguard Capital Management LLC holds 59,311,525 shares after an addition of 441,525 shares, growing its position by 0.8%. State Street Corporation has 45,633,267 shares, with a minor increase of 299,205 shares, up by 0.7%. Capital World Investors has 29,887,932 shares after gaining 2,103,297 shares, marking a 7.6% increase. Meanwhile, FMR, LLC reported a total of 27,992,995 shares, significantly increasing its holdings by 15,974,192 shares, which is a 132.9% jump.

UnitedHealth Group Incorporated Stock Up 1.8%

As of October 16, 2026, UnitedHealth Group shares are trading recently around $402.70. This price is above its 50-day moving average of $387.35 and its 200-day moving average of $358.75, suggesting the stock is currently performing well. However, it is about 12.8% below its 52-week high of $461.62, indicating some room for recovery.

Recent Earnings

UnitedHealth Group reported trailing twelve-month revenue of $450.1 billion and an earnings per share (EPS) of $15.55. The company has a net margin of 3.5% and a return on equity of 15.8%. Its next earnings report is set for January 26, 2027.

Insider Buying and Selling at UnitedHealth Group Incorporated

In recent insider transactions, several executives have made moves. Chief Accounting Officer Dennis Andrew Stankiewicz bought 51 shares on June 23, 2026, while CEO of Optum Patrick Hugh Conway purchased 83 shares on the same date. However, Conway also sold 500 shares at an average price of $410 on August 5, 2026, followed by another sale of 1,169 shares at an average price of $390 on August 21, 2026.

Analysts Set New Price Targets

On October 16, 2026, Bernstein maintained its Outperform rating on UnitedHealth Group, setting a price target of $500. Also on the same day, JP Morgan reaffirmed its Overweight rating with a target of $524. Earlier, on October 14, 2026, Piper Sandler maintained its Overweight rating with a price target of $504, while Barclays kept its Overweight rating with a target of $440. TD Cowen reiterated a Hold rating with a target of $402 on October 15, 2026. The consensus rating remains a buy, with a mean price target of $477.04 based on 25 analyst opinions.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a healthcare company offering various services, including care delivery and management. It operates through segments like Optum Health and UnitedHealthcare. This position cut may indicate a shift in strategies for Global Strategic Investment Solutions regarding healthcare investments.

Bottom Line

Looking ahead, investors will be watching for UnitedHealth's next earnings report on January 26, 2027. Keep in mind that this 13F filing reflects positions as of the reporting period and may not represent the fund's current holdings. Keep in mind that 13F filings are backward-looking: they show holdings as of the end of the reporting quarter and may not represent the fund's current position.